Jose Luis Alccacontor Muñoz

Mr. Jose Luis Alccacontor Muñoz

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
MCMartha Vanessa Fernández Baca C
Martha Vanessa Fernández Baca C
ACAlejandro Castellanos-Gonzalez
Alejandro Castellanos-Gonzalez
Rodrigo Alejandro Ore VelardeRodrigo Alejandro Ore Velarde
Rodrigo Alejandro Ore Velarde
Jose Luis Alccacontor MuñozJose Luis Alccacontor Muñoz
Jose Luis Alccacontor Muñoz
CHCristian Hoban
Cristian Hoban
OPOn Behalf Of The Fasciola Tmrc In Peru
On Behalf Of The Fasciola Tmrc In Peru
Fasciola hepatica has a complex lifecycle with multiple intermediate and definitive hosts and influenced by environmental factors. The disease causes significant morbidity in children and its prevalent worldwide. There is lack of data about distribution and burden of the disease in endemic regions, owing to poor efficacy of the different diagnostic methods used. A novel PCR-based test was developed by using a portable mini-PCR® platform to detect Fasciola sp. DNA and interpret the results via a fluorescence viewer and smartphone image analyzer application. Human stool, snail tissue, and water samples were used to extract DNA. Primers targeting the ITS-1 of the 18S rDNA gene of Fasciola sp. were used. The limit of detection of the mini-PCR test was 1 fg/μL for DNA samples diluted in water, 10 fg/μL for Fasciola/snail DNA scramble, and 100 fg/μL for Fasciola/stool DNA scramble. The product detection by agarose gel, direct visualization, and image analyses showed the same sensitivity. The Fh mini-PCR had a sensitivity and specificity equivalent to real-time PCR using the same specimens. Testing was also done on infected human stool and snail tissue successfully. These experiments demonstrated that Fh mini-PCR is as sensitive and specific as real time PCR but without the use of expensive equipment and laboratory facilities. Further testing of multiple specimens with natural infection will provide evidence for feasibility of deployment to resource constrained laboratories.